EXPOSURE TO SHEAR-STRESS ALTERS ENDOTHELIAL ADHESIVENESS - ROLE OF NITRIC-OXIDE

被引:153
作者
TSAO, PS [1 ]
LEWIS, NP [1 ]
ALPERT, S [1 ]
COOKE, JP [1 ]
机构
[1] STANFORD UNIV,DIV CARDIOVASC MED,VASC MED SECT,STANFORD,CA 94305
关键词
ATHEROSCLEROSIS; ENDOTHELIUM-DERIVED FACTORS; LEUKOCYTES; FLOW;
D O I
10.1161/01.CIR.92.12.3513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Shear stress increases the release of nitric oxide (NO) by endothelial cells (ECs). We and others have provided evidence that endothelium-derived NO inhibits monocyte adhesion to the vessel wall. We therefore hypothesized that previous exposure to shear stress would inhibit endothelial adhesiveness for monocytes by virtue of its effect to increase NO release. Methods and Results Confluent monolayers of bovine aortic endothelial cells, human aortic endothelial cells, or human venous endothelial cells were exposed to laminar fluid flow. Culture media were collected for measurement of NO (by chemiluminescence) and the prostacyclin metabolite 6-ketoprostaglandin F-1 alpha. NOx and 6-keto-prostaglandin F1 alpha accumulated in the conditioned medium during laminar fluid flow from 30 minutes to 24 hours in a time-dependent fashion. In another set of studies, ECs previously exposed to pow or to static conditions were washed with Hanks' buffer and exposed to THP-1 cells for 30 minutes. Adherent cells were counted by microscopy. Previous exposure to flow reduced endothelial adhesiveness for monocytes by 50% (P<.05). The effect of flow on endothelial adhesiveness occurred within 30 minutes. This effect was abrogated by nitro-L-arginine (an antagonist of NO synthesis), as well as by tetraethylammonium ion (an antagonist of the flow-activated potassium channel); the effects of these inhibitors were reversed by the NO donor SPM-5185. Although the cyclo-oxygenase inhibitor Indomethacin totally inhibited the flow-induced production of prostacyclin by ECs, it minimally affected adherence of THP-1 cells. The early effect of flow on endothelial adhesiveness was not mediated by alterations in the expression of the endothelial adhesion molecules VCAM-1 or ICAM-1 as assessed by fluorescent activated cell sorting. Conclusions Shear stress alters endothelial adhesiveness for monocytes; at early time points, this effect is largely due to how-stimulated release of NO and, to a lesser extent, prostacyclin. This effect of flow occurs within 30 minutes and is probably due to alterations in the signal transduction or activation state (rather than the expression) of endothelial adhesion molecules;
引用
收藏
页码:3513 / 3519
页数:7
相关论文
共 46 条
  • [1] [Anonymous], MECH VASODILATATION
  • [2] ASAKURA T, 1976, CIRC RES, V23, P489
  • [3] NITRIC-OXIDE AND PROSTACYCLIN - DIVERGENCE OF INHIBITORY EFFECTS ON MONOCYTE CHEMOTAXIS AND ADHESION TO ENDOTHELIUM INVITRO
    BATH, PMW
    HASSALL, DG
    GLADWIN, AM
    PALMER, RMJ
    MARTIN, JF
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02): : 254 - 260
  • [4] ARTERIAL-WALLS GENERATE FROM PROSTAGLANDIN ENDOPEROXIDES A SUBSTANCE (PROSTAGLANDIN-X) WHICH RELAXES STRIPS OF MESENTERIC AND CELIAC ARTERIES AND INHIBITS PLATELET-AGGREGATION
    BUNTING, S
    GRYGLEWSKI, R
    MONCADA, S
    VANE, JR
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (06) : 897 - 913
  • [5] CHRONIC INHIBITION OF NITRIC-OXIDE PRODUCTION ACCELERATES NEOINTIMA FORMATION AND IMPAIRS ENDOTHELIAL FUNCTION IN HYPERCHOLESTEROLEMIC RABBITS
    CAYATTE, AJ
    PALACINO, JJ
    HORTEN, K
    COHEN, RA
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05): : 753 - 759
  • [6] CHIHARA J, 1992, J LIPID MEDIATOR, V5, P159
  • [7] NITRIC-OXIDE, AN ENDOTHELIAL-CELL RELAXATION FACTOR, INHIBITS NEUTROPHIL SUPEROXIDE ANION PRODUCTION VIA A DIRECT ACTION ON THE NADPH OXIDASE
    CLANCY, RM
    LESZCZYNSKAPIZIAK, J
    ABRAMSON, SB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) : 1116 - 1121
  • [8] ANTIATHEROGENIC EFFECTS OF L-ARGININE IN THE HYPERCHOLESTEROLEMIC RABBIT
    COOKE, JP
    SINGER, AH
    TSAO, P
    ZERA, P
    ROWAN, RA
    BILLINGHAM, ME
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) : 1168 - 1172
  • [9] COOKE JP, 1992, J CLIN INVEST, V88, P1663
  • [10] COOKE JP, 1990, AM J PHYSIOL, V28, pH804